Assay ID | Title | Year | Journal | Article |
AID1745845 | Primary qHTS for Inhibitors of ATXN expression | | | |
AID588501 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set | 2010 | Current protocols in cytometry, Oct, Volume: Chapter 13 | Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening. |
AID588501 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set | 2006 | Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
| Microsphere-based protease assays and screening application for lethal factor and factor Xa. |
AID588501 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set | 2010 | Assay and drug development technologies, Feb, Volume: 8, Issue:1
| High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors. |
AID588499 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set | 2010 | Current protocols in cytometry, Oct, Volume: Chapter 13 | Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening. |
AID588499 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set | 2006 | Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
| Microsphere-based protease assays and screening application for lethal factor and factor Xa. |
AID588499 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set | 2010 | Assay and drug development technologies, Feb, Volume: 8, Issue:1
| High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors. |
AID651635 | Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression | | | |
AID588497 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set | 2010 | Current protocols in cytometry, Oct, Volume: Chapter 13 | Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening. |
AID588497 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set | 2006 | Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
| Microsphere-based protease assays and screening application for lethal factor and factor Xa. |
AID588497 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set | 2010 | Assay and drug development technologies, Feb, Volume: 8, Issue:1
| High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors. |
AID91409 | Inhibition of HIV-1 integrase enzyme at 3`- processing stage of DNA integration | 1998 | Journal of medicinal chemistry, Aug-13, Volume: 41, Issue:17
| Salicylhydrazine-containing inhibitors of HIV-1 integrase: implication for a selective chelation in the integrase active site. |
AID312518 | Inhibition of recombinant HIV1 integrase strand transfer activity in presence of manganese | 2008 | Journal of medicinal chemistry, Jan-24, Volume: 51, Issue:2
| 2,3-dihydro-6,7-dihydroxy-1H-isoindol-1-one-based HIV-1 integrase inhibitors. |
AID47145 | Effective concentration was evaluated on HIV-1 infected CEM cells.(NR-not reached due to cytotoxicity.) | 1998 | Journal of medicinal chemistry, Aug-13, Volume: 41, Issue:17
| Salicylhydrazine-containing inhibitors of HIV-1 integrase: implication for a selective chelation in the integrase active site. |
AID93671 | Inhibitory activity against HIV-1 integrase (pre-incubated with Mn+2, and DNA on ice for 15 min followed by drug for 1h) in 3'' processing of postassembly | 2002 | Journal of medicinal chemistry, Dec-19, Volume: 45, Issue:26
| Metal-dependent inhibition of HIV-1 integrase. |
AID93672 | Inhibitory activity against HIV-1 integrase (pre-incubated with Mn+2, and DNA on ice for 15 min followed by drug for 1h) in strand transfer of postassembly | 2002 | Journal of medicinal chemistry, Dec-19, Volume: 45, Issue:26
| Metal-dependent inhibition of HIV-1 integrase. |
AID91412 | Inhibitory concentration as 50% inhibition of HIV-1 integrase enzyme at strand transfer stage of DNA integration. | 1998 | Journal of medicinal chemistry, Aug-13, Volume: 41, Issue:17
| Salicylhydrazine-containing inhibitors of HIV-1 integrase: implication for a selective chelation in the integrase active site. |
AID93673 | Inhibitory activity against HIV-1 integrase (pre-incubated with Mn+2, and drug for 30 min followed by DNA for 1h) in 3''-processing of preassemble | 2002 | Journal of medicinal chemistry, Dec-19, Volume: 45, Issue:26
| Metal-dependent inhibition of HIV-1 integrase. |
AID312519 | Antiviral activity against HIV1 in cell based assay | 2008 | Journal of medicinal chemistry, Jan-24, Volume: 51, Issue:2
| 2,3-dihydro-6,7-dihydroxy-1H-isoindol-1-one-based HIV-1 integrase inhibitors. |
AID93547 | Inhibitory activity against HIV-1 integrase (pre-incubated with Mg+2, and drug for 30 min followed by DNA for 1h) in strand transfer of preassemble | 2002 | Journal of medicinal chemistry, Dec-19, Volume: 45, Issue:26
| Metal-dependent inhibition of HIV-1 integrase. |
AID312517 | Inhibition of recombinant HIV1 integrase strand transfer activity in presence of magnesium | 2008 | Journal of medicinal chemistry, Jan-24, Volume: 51, Issue:2
| 2,3-dihydro-6,7-dihydroxy-1H-isoindol-1-one-based HIV-1 integrase inhibitors. |
AID47438 | Tested for HIV-1 replication in CEM cells. | 1998 | Journal of medicinal chemistry, Aug-13, Volume: 41, Issue:17
| Salicylhydrazine-containing inhibitors of HIV-1 integrase: implication for a selective chelation in the integrase active site. |
AID93546 | Inhibitory activity against HIV-1 integrase (preincubated with Mg+2, and drug for 30 min followed by DNA for 1h) in 3''-processing of preassemble | 2002 | Journal of medicinal chemistry, Dec-19, Volume: 45, Issue:26
| Metal-dependent inhibition of HIV-1 integrase. |
AID93544 | Inhibitory activity against HIV-1 integrase (pre-incubated with Mg+2, and DNA on ice for 15 min followed by drug for 1h) in 3'' processing of postassembly | 2002 | Journal of medicinal chemistry, Dec-19, Volume: 45, Issue:26
| Metal-dependent inhibition of HIV-1 integrase. |
AID93517 | Inhibition of HIV-1 integrase enzyme by 3'-processing method | 1997 | Journal of medicinal chemistry, Mar-14, Volume: 40, Issue:6
| Hydrazide-containing inhibitors of HIV-1 integrase. |
AID93680 | Inhibitory activity against HIV-1 integrase | 2004 | Bioorganic & medicinal chemistry letters, Mar-22, Volume: 14, Issue:6
| HIV-1 integrase pharmacophore model derived from diverse classes of inhibitors. |
AID93545 | Inhibitory activity against HIV-1 integrase (pre-incubated with Mg+2, and DNA on ice for 15 min followed by drug for 1h) in strand transfer of postassembly | 2002 | Journal of medicinal chemistry, Dec-19, Volume: 45, Issue:26
| Metal-dependent inhibition of HIV-1 integrase. |
AID93674 | Inhibitory activity against HIV-1 integrase (pre-incubated with Mn+2, and drug for 30 min followed by DNA for 1h) in strand transfer of preassemble | 2002 | Journal of medicinal chemistry, Dec-19, Volume: 45, Issue:26
| Metal-dependent inhibition of HIV-1 integrase. |
AID93520 | Inhibition of HIV-1 integrase enzyme | 1997 | Journal of medicinal chemistry, Mar-14, Volume: 40, Issue:6
| Hydrazide-containing inhibitors of HIV-1 integrase. |
AID199986 | Cytotoxic concentration against viral replication by Reverse transcriptase | 2002 | Journal of medicinal chemistry, Dec-19, Volume: 45, Issue:26
| Metal-dependent inhibition of HIV-1 integrase. |
AID312515 | Inhibition of recombinant HIV1 integrase-mediated 3'-processing activity in presence of magnesium | 2008 | Journal of medicinal chemistry, Jan-24, Volume: 51, Issue:2
| 2,3-dihydro-6,7-dihydroxy-1H-isoindol-1-one-based HIV-1 integrase inhibitors. |
AID312516 | Inhibition of recombinant HIV1 integrase-mediated 3'-processing activity in presence of manganese | 2008 | Journal of medicinal chemistry, Jan-24, Volume: 51, Issue:2
| 2,3-dihydro-6,7-dihydroxy-1H-isoindol-1-one-based HIV-1 integrase inhibitors. |
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |